214 related articles for article (PubMed ID: 34620743)
1. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
Wang Q; Shi M
Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
[TBL] [Abstract][Full Text] [Related]
2. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
3. Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus.
Li Q; Xu H; Sui C; Zhang H
Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101781. PubMed ID: 34332136
[TBL] [Abstract][Full Text] [Related]
4. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
He XK; Su TT; Si JM; Sun LM
Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
[TBL] [Abstract][Full Text] [Related]
5. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis.
Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C
Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study.
Cardel M; Jensen SM; Pottegård A; Jørgensen TL; Hallas J
Cancer Med; 2014 Oct; 3(5):1458-66. PubMed ID: 25091592
[TBL] [Abstract][Full Text] [Related]
8. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis.
Yang WT; Yang HJ; Zhou JG; Liu JL
Int J Colorectal Dis; 2020 Nov; 35(11):2117-2131. PubMed ID: 32720184
[TBL] [Abstract][Full Text] [Related]
9. [Metformin can reduce the risk of colorectal cancer].
Fransgård T; Gögenur I
Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593
[TBL] [Abstract][Full Text] [Related]
10. Metformin use and prostate cancer risk: A meta-analysis of cohort studies.
Feng Z; Zhou X; Liu N; Wang J; Chen X; Xu X
Medicine (Baltimore); 2019 Mar; 98(12):e14955. PubMed ID: 30896668
[TBL] [Abstract][Full Text] [Related]
11. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.
Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE
Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223
[TBL] [Abstract][Full Text] [Related]
12. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer.
Dimberg J; Shamoun L; Landerholm K; Wågsäter D
World J Gastroenterol; 2022 May; 28(19):2148-2151. PubMed ID: 35664033
[TBL] [Abstract][Full Text] [Related]
13. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
14. Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis.
Petrelli F; Ghidini M; Rausa E; Ghidini A; Cabiddu M; Borgonovo K; Ghilardi M; Parati MC; Pietrantonio F; Sganzerla P; Bossi AC
Can J Diabetes; 2021 Mar; 45(2):186-197.e2. PubMed ID: 33039329
[TBL] [Abstract][Full Text] [Related]
15. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.
Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM
Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092
[TBL] [Abstract][Full Text] [Related]
16. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
Wang Y; Xiao J; Zhao Y; Du S; Du J
Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
[TBL] [Abstract][Full Text] [Related]
17. Metformin and Colorectal Cancer - A Systematic Review.
Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
[TBL] [Abstract][Full Text] [Related]
18. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh H; Singh PP; Murad MH; Limburg PJ
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2258-68. PubMed ID: 24042261
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
